Matin K - Search Results

1

Phase II study of docetaxel and gefitinib as second-line therapy in gemcitabine pretreated patients with advanced pancreatic cancer.

Brell JM, Matin K, Evans T, Volkin RL, Kiefer GJ, Schlesselman JJ, Dranko S, Rath L, Schmotzer A, Lenzner D, Ramanathan RK. Brell JM, et al. Among authors: matin k. Oncology. 2009;76(4):270-4. doi: 10.1159/000206141. Epub 2009 Mar 4. Oncology. 2009. PMID: 19258727 Clinical Trial.

2

A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancer.

Matin K, Jacobs SA, Richards T, Wong MK, Earle M, Evans T, Troetschel M, Ferri W, Friedland D, Pinkerton R, Volkin R, Wieand S, Ramanathan RK. Matin K, et al. Am J Clin Oncol. 2005 Oct;28(5):439-44. doi: 10.1097/01.coc.0000170797.36351.3a. Am J Clin Oncol. 2005. PMID: 16199980 Clinical Trial.

3

Phase II study of rubitecan, an oral camptothecin in patients with advanced colorectal cancer who have failed previous 5-fluorouracil based chemotherapy.

Patel H, Stoller R, Auber M, Potter D, Cai C, Zamboni W, Kiefer G, Matin K, Schmotzer A, Ramanathan RK. Patel H, et al. Among authors: matin k. Invest New Drugs. 2006 Jul;24(4):359-63. doi: 10.1007/s10637-006-6451-2. Invest New Drugs. 2006. PMID: 16525767 Clinical Trial.

4

Phase 1 Study of Neoadjuvant Short-Course Radiation Therapy Concurrent With Infusional 5-Fluorouracil for the Treatment of Locally Advanced Rectal Cancer.

Fields EC, Kaplan BJ, Karlin J, Myers JL, Mukhopadhyay N, Deng X, Sankala H, Grossman SR, Matin K. Fields EC, et al. Among authors: matin k. Adv Radiat Oncol. 2019 May 11;4(4):605-612. doi: 10.1016/j.adro.2019.04.005. eCollection 2019 Oct-Dec. Adv Radiat Oncol. 2019. PMID: 31673654 Free PMC article.

5

Effectiveness of a Multimedia Educational Intervention to Improve Understanding of the Risks and Benefits of Palliative Chemotherapy in Patients With Advanced Cancer: A Randomized Clinical Trial.

Enzinger AC, Uno H, McCleary N, Frank E, Sanoff H, Van Loon K, Matin K, Bullock A, Cronin C, Cibotti H, Bagley J, Schrag D. Enzinger AC, et al. Among authors: matin k. JAMA Oncol. 2020 Aug 1;6(8):1265-1270. doi: 10.1001/jamaoncol.2020.1921. JAMA Oncol. 2020. PMID: 32672806 Free PMC article. Clinical Trial.

6

Phase I and pharmacokinetic study of vinblastine and high-dose megestrol acetate.

Matin K, Egorin MJ, Ballesteros MF, Smith DC, Lembersky B, Day RS, Johnson CS, Trump DL. Matin K, et al. Cancer Chemother Pharmacol. 2002 Sep;50(3):179-85. doi: 10.1007/s00280-002-0484-9. Epub 2002 Jul 19. Cancer Chemother Pharmacol. 2002. PMID: 12203099 Clinical Trial.

7

Uncommon presentations of some common malignancies: Case 3. Chronic lymphocytic leukemia involving the colon and presenting with perforation.

Lalani M, Rhee JC, Gutkin DW, Matin K, Ahmad J. Lalani M, et al. Among authors: matin k. J Clin Oncol. 2005 Feb 20;23(6):1315-7. doi: 10.1200/JCO.2005.02.187. J Clin Oncol. 2005. PMID: 15718331 No abstract available.

8

Adjuvant radiation therapy for T4 non-rectal colon adenocarcinoma provides a cause-specific survival advantage: A SEER database analysis.

McLaughlin C, Kim NK, Bandyopadhyay D, Deng X, Kaplan B, Matin K, Fields EC. McLaughlin C, et al. Among authors: matin k. Radiother Oncol. 2019 Apr;133:50-53. doi: 10.1016/j.radonc.2018.11.026. Epub 2019 Jan 16. Radiother Oncol. 2019. PMID: 30935581 Free PMC article.

9

The Effect of Disclosing Life Expectancy Information on Patients' Prognostic Understanding: Secondary Outcomes From a Multicenter Randomized Trial of a Palliative Chemotherapy Educational Intervention.

Enzinger AC, Uno H, McCleary N, Frank E, Sanoff H, Van Loon K, Matin K, Bullock A, Cronin C, Bagley J, Schrag D. Enzinger AC, et al. Among authors: matin k. J Pain Symptom Manage. 2021 Jan;61(1):1-11.e3. doi: 10.1016/j.jpainsymman.2020.07.025. Epub 2020 Aug 7. J Pain Symptom Manage. 2021. PMID: 32777456 Free PMC article. Clinical Trial.

10

Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement.

Oyer RA, Hurley P, Boehmer L, Bruinooge SS, Levit K, Barrett N, Benson A, Bernick LA, Byatt L, Charlot M, Crews J, DeLeon K, Fashoyin-Aje L, Garrett-Mayer E, Gralow JR, Green S, Guerra CE, Hamroun L, Hardy CM, Hempstead B, Jeames S, Mann M, Matin K, McCaskill-Stevens W, Merrill J, Nowakowski GS, Patel MI, Pressman A, Ramirez AG, Segura J, Segarra-Vasquez B, Hanley Williams J, Williams JE Jr, Winkfield KM, Yang ES, Zwicker V, Pierce LJ. Oyer RA, et al. Among authors: matin k. J Clin Oncol. 2022 Jul 1;40(19):2163-2171. doi: 10.1200/JCO.22.00754. Epub 2022 May 19. J Clin Oncol. 2022. PMID: 35588469

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters